Sign Up Now for Our Exclusive Breakfast Symposium & Connect With the IceCure Team!
Are you a breast surgeon looking for innovative, minimally invasive treatment options for low-risk breast cancer? Don’t miss your chance to discover the latest breakthroughs in breast cryoablation with ProSense® at the American Society of Breast Surgeons Annual Meeting in Seattle, WA, from April 30 – May 3, 2026.
Visit IceCure at booth 322 and secure your place at our highly anticipated breakfast symposium. Register now to learn how ProSense®, recently FDA-cleared for local treatment of low-risk breast cancer in patients aged 70 and older alongside endocrine therapy, is revolutionizing care and expanding your surgical toolkit.
Breakfast Symposium: Unlocking De-Escalation of Care Cryoablation for Breast Cancer
Date: Friday, May 1
Time: 6:30–7:45 AM PT
Location: Seattle Convention Center, Ballroom 6B
Join IceCure’s ASBrS inaugural symposium and explore how cryoablation is changing the landscape of local treatment for low-risk breast cancer patients.
Learn about:
- The role of cryoablation in de-escalating breast cancer care
- Clinical evidence on safety and efficacy
- Steps to implement and expand a cryoablation program
- Post-cryoablation follow-up protocols
- Hands-on procedural insights from leading experts
Led by a distinguished multidisciplinary faculty, including breast surgeons Richard E. Fine, MD, FACS, Michael S. Sabel, MD, Lauren Kopicky, DO, and radiologist Robert C. Ward, MD, this symposium offers invaluable guidance on integrating cryoablation into clinical practice. Click here to register for the symposium!
Take Action: Reserve Your Seat & Connect With Us!
Seats are limited to 75 participants. Sign up today to secure your spot in the symposium or sign up meet with IceCure at ASBrS.
*The breast cancer indication for the ProSense® System is currently under review by the FDA and has not yet received marketing clearance in the US. ProSense™ is cleared for the treatment of breast cancer in the EU and other select markets. Clinical indications vary by region, please contact us for additional details.